TOP STORIES

• BUSINESS AbbVie Japan Looks to Double Sales by 2029 with Rinvoq and Skyrizi as Engines
  June 12, 2025

• BUSINESS Prashant Nikam to Take Over Helm of MSD Japan
  June 12, 2025

• BUSINESS Taking on Solid Tumors - 5: Genmab Pursuing Unique T-Cell Engager Program for Lung Cancer
  June 11, 2025

• BUSINESS Taking on Solid Tumors - 4: With 2 Late-Stage Assets in Wings, Will AstraZeneca Reshape CP Inhibitor Landscape?
  June 10, 2025

• REGULATORY LDP Lawmakers Push Back on Honebuto Draft over CEA, Social Security Budgeting
  June 10, 2025

• REGULATORY Honebuto Draft Urges Promotion of Drug Innovation, but Spells Out CEA Expansion Too
  June 9, 2025

• BUSINESS Takeda Rolls Out AI Tool to Guide “Next Best Action” in Sales
  June 6, 2025

• ORGANIZATION New FPMAJ Chair Pushes Category-Based Drug Pricing to Ensure Innovation, Stable Supply
  June 5, 2025

• REGULATORY Early Honebuto Draft Contains CEA Expansion, Ramp-Up of FIH Trial Sites
  June 4, 2025

• ORGANIZATION New JPMA Chief Calls for Clear-Cut Evaluation of Innovation in FY2026 Reform
  June 3, 2025

• REGULATORY New Skipper of PMDA’s Review Center Wears Multiple Hats to Push Fight against Drug Loss
  June 2, 2025

• BUSINESS Taking on Solid Tumors - 3: J&J to Soon Have 3 Bispecifics in Japan as Rybrevant Gathers Pace
  May 30, 2025

• BUSINESS Towa, Sawai Log Two-Digit Growth in Operating Profit, but Industry Sees Divide: Tally
  May 30, 2025

• BUSINESS Taking on Solid Tumors - 2: Chugai Poised to Break through Solid Cancer “Wall” with Trispecific Antibodies
  May 29, 2025

• REGULATORY LDP Pharma Study Group’s Final Proposal Urges Raising of Social Security Budget Ceiling
  May 29, 2025

• REGULATORY LDP Fiscal Reform HQ’s Proposal Keeps Budget Ceiling Intact, but Urges Action on Wage Front
  May 28, 2025

• REGULATORY MOF Panel Again Presses for Expansion of CEA Scheme: “Spring” Proposal
  May 27, 2025

• REGULATORY Honebuto Outline Includes “Raise in Official Prices,” but Details Yet Unknown
  May 27, 2025

• COMMENTARY Next Wave of ALS Drugs Emerging as Novartis, Nipro Enter Development Fray
  May 27, 2025

• BUSINESS Sun Pharma Japan Eyes 10%-Plus CAGR as It Pivots to New Drug Biz
  May 26, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• …
• Next ›
• 最終 »